ArticleMethods in molecular biology (Clifton, N.J.)2026
Microfluidic Device Manufacturing by Light-Based 3D Printing for Organoid Vascularization.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Organ-on-a-Chip: A Roadmap for Translational Research in Human and Veterinary Medicine.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
3D printing by light-based vat polymerization enables the manufacturing of a variety of microfluidic devices which can be used to study growth, patterning, vascularization, and tissue interactions of stem cell-derived spheroids, organoids, and tissue explants. This technology allows to design and manufacture compartmentalized devices for precise seeding of cells and organoids, combined with the possibility to generate controlled media flow. Here, we detail the steps involved in the fabrication of such microfluidic devices, including the printing and post-processing stages using light-based 3D printing. We also give an example of how such a 3D printed microfluidic device can be used to culture and vascularize cerebral organoids. The use of 3D printing provides a rapid and inexpensive way to generate microfluidic devices without the need for cleanroom facilities and is therefore a technology accessible to every life science research lab. In addition, this high throughput method facilitates organoid studies in a more controlled environment, thereby representing a significant advancement in reproducibility for organoid research.
Indexed as
Identifiers
40638016What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.